Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Spirit Scientific CoROCO:7790 +0.77%21 ROA % is 0.80% as of Dec. 2025, which is 51% below its 10-year median of 1.63. GuruFocus rates ROCO:7790 with a GF Score™ of 21/100. The stock has 2 warning signs investors should review. Among 1,416 Biotechnology companies, Spirit Scientific Co ranks better than 82.42% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Spirit Scientific Co's annualizedNet Income for the quarter that ended in Dec. 2025 was NT$4.0 Mil.
Spirit Scientific Co's average Total Assets over the quarter that ended in Dec. 2025 was NT$500.0 Mil. Therefore, Spirit Scientific Co's annualized ROA % for the quarter that ended in Dec. 2025 was 0.80%.
The historical rank and industry rank for Spirit Scientific Co's ROA % or its related term are showing as below:
ROCO:7790'
s ROA % Range Over the Past 10 Years
Min: -5.82 Med: 1.63 Max: 4.22
Current: 1.08
During the past 5 years, Spirit Scientific Co's highest ROA % was 4.22%. The lowest was -5.82%. And the median was 1.63%.
ROCO:7790's ROA % is ranked better than 82.42% of 1416
companies
in the Biotechnology industry
Industry Median: -32.87
vs ROCO:7790: 1.08
Spirit Scientific Co (ROCO:7790) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Dec. 2025) net income data. The Revenue data used here is four times the quarterly (Dec. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Spirit Scientific Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spirit Scientific Co ROA % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Spirit Scientific Co's ROA % distribution charts can be found below:
* The bar in red indicates where Spirit Scientific Co's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Dec. 2025) net income data.
ROA % is displayed in the 30-year financial page.
Spirit Scientific Co (ROCO:7790) has a ROA % of 0.80% as of Dec. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Spirit Scientific Co and its competitors. This is 51% below median its historical median of 1.63. According to the industry distribution chart, Spirit Scientific Co ranks #249 out of 1416 companies in the Biotechnology industry, placing it in the top 17.6%.
Is Spirit Scientific Co's ROA % too high?
Spirit Scientific Co's current ROA % of 0.80% is 51% below median its 10-year median of 1.63. Based on the distribution chart, Spirit Scientific Co ranks #249 out of 1416 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Spirit Scientific Co has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Spirit Scientific Co's ROA % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Spirit Scientific Co ranks #249 out of 1416 companies for ROA %. This places Spirit Scientific Co in the top 18% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Biotechnology company?
A good ROA % depends on the Biotechnology industry context. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Spirit Scientific Co and its competitors. Spirit Scientific Co's current ROA % is 0.80%, which is 51% below median its own 10-year median of 1.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spirit Scientific Co stock overvalued right now?
Spirit Scientific Co (ROCO:7790) has a current ROA % of 0.80%. The current ROA % is 0.80%, which is 51% below median its 10-year median of 1.63. Spirit Scientific Co's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Spirit Scientific Co (ROCO:7790), the current ROA % is 0.80% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Spirit Scientific Co Ltd is engaged in precision regenerative medicine, specializing in platelet cryocrystallization technology and Bio Material Lyophilized Technology (BMLT). The company provides solutions for extracting high-concentration platelet growth factors, enabling safe, flexible, and long-term storage therapies. Spirit Biotech delivers cutting-edge autologous healing reagent preparation services, along with OEM and ODM models. With a focus on unmet medical needs, the company transforms patented technologies into scalable solutions, advancing the future of regenerative healthcare.
21GF Score
Get the complete analysis for ROCO:7790
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7790 has been successfully added to your 
